Antacids Market Report 2026

Antacids Market Overview

• Antacids market size has reached to $9.94 billion in 2025 • Expected to grow to $11.57 billion in 2030 at a compound annual growth rate (CAGR) of 3.3% • Growth Driver: Rising Prevalence Of Inflammatory Bowel Disease Fuels Expansion Of Animal Growth Promoters And Performance Enhancers Market • Market Trend: Antacid Market Gets A Flavorful Boost With Innovative Offerings • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Antacids Market?

The antacids drugs refer to the drugs that are used to neutralize stomach acid, and treat acid reflux, heartburn, and indigestion. Antacids are medications that counteract (neutralize) your stomach's acid to ease heartburn and indigestion. They are available without a prescription from pharmacies and stores and come in liquid or chewable tablet form. It includes drug classes such as proton pump inhibitors, H2 antagonists, surgical simulators, and acid neutralizers in the form of tablets, liquid, or powder. The main classes of antacids are proton pump inhibitors, H2 antagonists, acid neutralizers, and pro-motility agents. Proton-pump inhibitors are a type of drug that reduces stomach acid production significantly and for a long time. They accomplish this by blocking the H+/K+ ATPase proton pump in the stomach in an irreversible manner. The different types of formulations include tablets, liquids, powders, and others and are distributed through various channels such as hospital pharmacies, retail pharmacies, and others.

What Is The Antacids Market Growth Forecast?

The antacids market size is expected to see steady growth in the next few years. It will grow to $11.57 billion in 2030 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine, rising demand for natural and herbal antacids, growth in e-pharmacy and online sales, technological advancements in drug delivery, expansion in emerging markets. Major trends in the forecast period include increasing over-the-counter availability, rise in combination antacid formulations, growing focus on pediatric and geriatric care, expansion of home healthcare solutions, shift towards natural and herbal antacids.

What Is The Driver Of The Antacids Market?

The increasing prevalence of inflammatory bowel disease is expected to drive the growth of antacids market. Inflammatory bowel disease (IBD) refers to a group of conditions characterized by chronic inflammation in the digestive tract. Antacids are medications designed to regulate stomach acid levels and are commonly employed for the management of heartburn and indigestion. For instance, according to the International Foundation for Gastrointestinal Disorders (IFFGD), a US-based non-profit education and research organization, it is estimated that 5–10% of the global population will have IBS in 2023 and between 25 and 45 million people in the United States are affected by IBS. Moreover, according to a survey by the American Gastroenterological Association covering 33 countries on 6 continents regarding the prevalence of and factors associated with functional gastrointestinal disorders, among the 73,076 adult respondents, more than 40% of persons worldwide have functional gastrointestinal disorders (FGID), which affect the quality of life and health care use. Therefore, the increasing prevalence of inflammatory bowel disease will be propelling the growth of antacids industry going forward.

Key Players In The Global Antacids Market

Major companies operating in the antacids market are Walmart Equate LLC, Private Label, Pfizer Inc, Bayer AG, Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Reckitt Benckiser Group plc, WellSpring Pharmaceutical Corporation, Xiuzheng Pharmaceutical Group Company Limited, Bausch Health Companies Inc., Sun Pharmaceuticals Industries Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Alkem Laboratories Ltd., Conba Group Co. Ltd., Chattem Chemicals Inc., China Resources Sanjiu Medical & Pharmaceutical Co. Ltd., Thornton and Ross Ltd., McNeil Consumer Pharmaceuticals Co., Advance Pharmaceutical Inc.

Global Antacids Market Trends and Insights

Major companies operating in the antacids market are innovating new products, multiple antacid flavors to increase their profitability in the market. Antacid flavors refer to the different flavors that are available for antacid products. For instance, in March 2023 Wonderbelly, a US-based digestive medicine company launched three antacid flavors which are Fruity Cereal, which is exclusive to Target stores, Strawberry Milkshake and Watermelon Mint. Wonderbelly Antacid contains the same active ingredient, calcium carbonate, as other brands. However, it sets itself apart by being a non-GMO and vegan product, devoid of talc, dyes, gluten, dairy, common allergens, synthetic sweeteners, artificial flavors, parabens, and preservatives. These products were developed in collaboration with gastroenterologists and pharmaceutical manufacturers to guarantee their quality.

Global Antacids Market Trends and Insights

Major companies operating in the antacids market are innovating new products, such as anti-reflux antacid, to address growing consumer demand for effective heartburn and acid reflux solutions. Anti-reflux antacids refer to medications specifically formulated to alleviate symptoms of gastroesophageal reflux disease (GERD) and related conditions by neutralizing stomach acid. For instance, in June 2024, Akums Drugs and Pharmaceuticals, an India-based pharmaceutical preparation manufacturing company, launched a new chewable tablet designed for heartburn relief, combining sodium alginate and potassium bicarbonate. Approved by the Drugs Controller General of India (DCGI), this dual-action formulation aims to provide effective relief from gastroesophageal reflux disease (GERD) symptoms. Sodium alginate forms a protective gel barrier to prevent acid reflux, while potassium bicarbonate neutralizes stomach acid for immediate relief.

What Defines the Antacids Market?

The antacids market consists of sales of Alka Seltzer, Maalox, Mylanta, Rolaids, Tums, and Pepto-Bismol. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Antacids Market Report 2026?

The antacids market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antacids industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.